Mechanism of Hypoxia-Induced NF-κB
Open Access
- 1 October 2010
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 30 (20) , 4901-4921
- https://doi.org/10.1128/mcb.00409-10
Abstract
NF-κB activation is a critical component in the transcriptional response to hypoxia. However, the underlying mechanisms that control its activity under these conditions are unknown. Here we report that under hypoxic conditions, IκB kinase (IKK) activity is induced through a calcium/calmodulin-dependent kinase 2 (CaMK2)-dependent pathway distinct from that for other common inducers of NF-κB. This process still requires IKK and the IKK kinase TAK1, like that for inflammatory inducers of NF-κB, but the TAK1-associated proteins TAB1 and TAB2 are not essential. IKK complex activation following hypoxia requires Ubc13 but not the recently identified LUBAC (linear ubiquitin chain assembly complex) ubiquitin conjugation system. In contrast to the action of other NF-κB inducers, IKK-mediated phosphorylation of IκBα does not result in its degradation. We show that this results from IκBα sumoylation by Sumo-2/3 on critical lysine residues, normally required for K-48-linked polyubiquitination. Furthermore, inhibition of specific Sumo proteases is sufficient to release RelA from IκBα and activate NF-κB target genes. These results define a novel pathway regulating NF-κB activation, important to its physiological role in human health and disease.Keywords
This publication has 42 references indexed in Scilit:
- Emerging roles of desumoylating enzymesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Hypoxia sensing and pathways of cytosolic Ca2+ increasesCell Calcium, 2004
- TAB3, a new binding partner of the protein kinase TAK1Biochemical Journal, 2004
- p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor SuppressorMolecular Cell, 2003
- The Rel/NF-κB family: friend and foeTrends in Biochemical Sciences, 2000
- The Rel/NF-κB signal transduction pathway: introductionOncogene, 1999
- SUMO-1 Modification of IκBα Inhibits NF-κB ActivationMolecular Cell, 1998
- Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high-altitude pulmonary edemaRespiration Physiology, 1998
- Endothelin-1 and interleukin-8 in high altitude pulmonary oedemaEuropean Respiratory Journal, 1996
- Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues.1994